Download presentation
Presentation is loading. Please wait.
Published byMadlyn Gilmore Modified over 9 years ago
1
5/9/20151 MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH TRAINING MODULE VACCINE AND MEDICATION PREPARATION AND ADMINISTRATION Presented by: Marie C. Regis DNP, RN Regional Immunization Nurse Metro Boston Region Massachusetts Department of Public Health November 9, 2010
2
5/9/20152 Learning Objectives Understand general guidelines of vaccine/medication preparation and administration Describe four different administration routes Describe infection control principles Describe patient preparation, comfort and safety Describe response to emergencies, adverse events, and errors List federal and state requirements for documentation and record keeping
3
5/9/20153 Correct Administration of Vaccines/Medications Keep current with best practices of vaccine/medication preparation and administration Adhere to agency policies for safety Use available resources and guidelines Complete accurate and legible documentation CDC
4
5/9/20154 Administration/Dispensing Best Practice Use 5 Rights of Medication Administration: Right Patient: verify name and age, screen for contraindications and precautions Right Drug: check label, review package insert, verify for appropriate patient/age Right Dose: determined by age and/or weight Right Route: e.g. IM, subcutaneous, PO, intranasal Right Time: refer to dosing schedules and minimum intervals between doses
5
5/9/20155 Standing Orders Use current medication and emergency standing orders that are reviewed and signed by a physician or Medical Director (vaccine/medication specific & emergency orders) Have signed orders at clinic site Orders should include: name of vaccine/medication, dose, route/method of administration and inclusion/exclusion criteria Model vaccine standing orders available at: http://www.mass.gov/dph/imm http://www.mass.gov/dph/imm
6
5/9/20156 Confidentiality and Privacy Assure the confidentiality of patients’ information and their rights to privacy Provide privacy at stations with screens and adequate space Ask only what you “need to know” for safe administration of vaccine or medication Comply with HIPAA and FERPA
7
5/9/20157 Vaccine Information Statement (VIS) Developed by CDC Conveys risks and benefits of vaccine Required by federal law Vaccine specific Must use current edition (unaltered) Must be given before each dose of each vaccine Provide an opportunity for questions Available in multiple languages at: www.immunize.org/vis
8
5/9/20158 Medication Information Sheet Name and formulation of medication Directions for use Dosing administration information Signs & symptoms of adverse reactions/side effects Provide an opportunity for questions
9
5/9/20159 Use appropriate screening tool Limit questions to “need to know” Vaccinator/dispenser responsible for final review of screening questions Protect confidentiality and privacy Sample immunization screening tools available at http://www.immunize.orghttp://www.immunize.org Request an interpreter if needed Screening for Contraindications and Precautions
10
5/9/201510 Screening for Contraindications and Precautions (cont.) Know your package insert! Some important considerations are: Anaphylaxis/Allergy Age Acute illness Underlying medical conditions Pregnancy Vaccination history Current medications
11
5/9/201511 Vaccine Formulations CA DPH
12
5/9/201512 Injectable Vaccine Preparation Always use sterile technique Check expiration date, color and consistency Follow package insert instructions
13
5/9/201513 Preparation: Reconstituting Vaccine/Medication Clean diluent vial stopper with alcohol and place vial on flat surface Instill air equal to dosage into vial Invert vial and withdraw diluent Clean vaccine/medication vial stopper with alcohol and place vial on flat surface Inject diluent into vaccine/medication vial Mix vaccine/medication and diluent per package insert instructions. When mixed, it should look as described in the package insert (e.g. color, no extraneous particulate matter, etc.) CA DPH
14
5/9/201514 Preparation: Drawing up Injectable Vaccine/Medication Clean vial stopper with alcohol between each needle insertion and place vial on flat surface Instill air equal to dosage into multidose vial Invert vial and withdraw dose into syringe Expel bubbles and excess liquid while needle in vial Recap needle, and label syringe if not using immediately (initials, contents, time, and date)
15
5/9/201515 Multi-Dose Vial Contains a preservative Good until expiration date unless contaminated, or manufacturer or package insert states otherwise Date, time and initial vial after opening Use open vial first and rotate stock CDC
16
Vaccinator Prefilling of Syringes In order to reduce the risk of medication administration errors and ensure vaccine viability, providers should avoid pre-filling syringes, and this practice is strongly discouraged. In situations where pre-filling syringes is unavoidable, medication administration errors may be reduced by: Storing syringes with vaccine of same type and same lot number together in separate containers Labeling each container and labeling each syringe with: Type of vaccine; lot number Date and time vaccine was drawn up Initials of the person who drew up vaccine
17
5/9/201517 Vaccinator Prefilling of Syringes May result in vaccine/medication administration errors and wastage Keep prefilled syringes on cold packs, and protect from light. If kept at room temperature, discard after 30 minutes Discard unused, prefilled syringes at end of the clinic day Consider using manufacturer-supplied prefilled syringes (if available) for large immunization events CDC
18
5/9/201518 Manufacturer Prefilled Syringes Most contain no, or only trace amounts of, preservative Removing the syringe cap or attachment of a needle breaks the sterile seal Do not remove the cap or attach a needle until ready to use Once needle attached, unused syringes should be discarded at end of the clinic day CDC
19
5/9/201519 Single Dose Vial Most contain no, or only trace amounts of, preservative Once opened, vial should be used or discarded at the end of the clinic day CDC
20
5/9/201520 Other Preparation Issues Not necessary to change needles between drawing up or reconstituting and administration unless needle is contaminated or bent Never mix different vaccines/medication in the same syringe unless approved by the FDA CDC
21
5/9/201521 Inactivated Vaccines Made from viruses and bacteria that have been killed (e.g. Tdap, pneumococcal vaccine) Can be given on same day as any other vaccine, live or inactivated Follow manufacturer’s recommended schedule for subsequent doses if applicable (e.g. Hepatitis B series)
22
5/9/201522 Live Vaccines Made from weakened (attenuated) virus in order to produce immune response without causing severe effects of disease (e.g. LAIV, MMR, varicella) Multiple live vaccines and inactivated vaccines can be given on same day, depending on administration route When administering live vaccines on different days, follow manufacturer’s instruction regarding necessary minimum intervals between doses (usually 28 days) CDC
23
5/9/201523 General Dosage Guidelines With any vaccine/medication formulation Refer to package insert (e.g. age, weight guidelines) Follow current standing orders Apply 5 rights of medication administration
24
5/9/201524 Administration Routes CA DPH
25
5/9/201525 Intramuscular (IM) Injection Sites Site selection depends on person’s age, muscle development and vaccine/medication Preferred vaccine site for children, adolescents and adults is upper arm (deltoid muscle) Vaccine site for toddlers can be either upper arm (deltoid) or anterolateral thigh (vastus lateralis) Vaccine site for infants is anterolateral thigh (vastus lateralis) Use anatomical landmarks to locate site CDC
26
5/9/201526 Intramuscular (IM) Injection Sites Infant/Child/Adolescent/Adult CDC Vastus Lateralis - infant site (alternative site when deltoid contraindicated) Deltoid - child and adult site
27
5/9/201527 Intramuscular (IM) Tissue Dermis Fatty Tissue Muscle Tissue 90°Angle CDC
28
5/9/201528 Intramuscular (IM) Sites and Needle Sizes www.immunize.org Patient AgeInjection SiteNeedle Size Newborn (0-28 days)Anterolateral thigh muscle5/8” (22-25 gauge) Infant (1-12 months)Anterolateral thigh muscle1” (22-25 gauge) Toddler (1-2 years) Anterolateral thigh muscle1-1 ¼” (22-25 gauge) Alternate site: Deltoid muscle5/8-1” (22-25 gauge) Children (3-18 years) Deltoid muscle5/8-1” (22-25 gauge) Alternate site: Anterolateral thigh muscle 1-1 ¼” (22-25 gauge) Adults (19 years and older) Deltoid muscle1-1 ½” (22-25 gauge) Alternate site: Anterolateral thigh muscle 1-1 ¼” (22-25 gauge)
29
5/9/201529 How to Locate Deltoid Muscle The injection site is 2-3 fingerbreadths below the shoulder tip (acromion), above level of armpit (axilla) and on the lateral midline of the arm. Draw an imaginary inverted triangle below the shoulder tip, using the above anatomical landmarks. The deltoid site for injection is the middle of the muscle (triangle). clavicle acromion axilla humerus
30
5/9/201530 Intramuscular (IM) Injection Technique Assess patient’s muscle mass Clean injection site with alcohol; allow to air dry With your dominant hand, insert needle at a 90-degree angle to the muscle Push down on plunger and inject entire contents of syringe Remove/retract needle and briefly apply light pressure to injection site with dry cotton ball or gauze Immediately put used syringe in sharps container Cover injection site with bandage if indicated CDC
31
5/9/201531 Intramuscular Injection (IM) Technique CDC
32
5/9/201532 Intramuscular (IM) Injection Site Infant CDC Anterolateral Thigh (vastus lateralis muscle)
33
5/9/201533 How to Locate Vastus Lateralis The anterolateral thigh Position client in supine or sitting position The upper landmark is the greater trochanter of the femur Injection site is the middle third and anterior lateral aspect of thigh The lower landmark is the lateral femoral condyle
34
5/9/201534 X Marks the Spot! Australian Gov’t Health & Aging
35
5/9/201535 Subcutaneous (SC) Injection Injection into the fatty tissue below the dermis and above the muscle Usual sites are thigh and upper outer triceps area of the arm CDC
36
5/9/201536 Subcutaneous Tissue 45° Angle CDC Dermis Muscle Tissue Fatty Tissue
37
5/9/201537 Subcutaneous (SC) Sites and Needle Sizes www.immunize.org Patient AgeInjection SiteNeedle length Birth to 12 months Fatty tissue over the anterolateral thigh muscle 5/8” (23-25 gauge) 12 months and older Fatty tissue over anterolateral thigh or fatty tissue over triceps 5/8” (23-25 gauge)
38
5/9/201538 Subcutaneous Injection Sites CDC
39
5/9/201539 Subcutaneous Injection Technique Clean injection site with alcohol; allow to air dry With thumb and index finger of your non-dominant hand, bunch fatty tissue of injection site With your dominant hand, insert needle at a 45-degree angle to skin; insert entire needle Push down on plunger and inject entire contents of syringe Remove needle and briefly apply light pressure with dry cotton ball or gauze to injection site Immediately put used syringe in sharps container Cover injection site with bandage if indicated CDC
40
5/9/201540 Subcutaneous Injection Technique CDC
41
5/9/201541 Injectable Administration Issues Aspiration not required for vaccines No reports of injury from failure to aspirate Can result in vaccine wastage When administering multiple doses at the same time, it is preferable to use separate limbs Injection sites in same limb should be separated by at least 1 inch if possible Use safety syringes/needles or needle-free devices to reduce risk of injury
42
5/9/201542 Oral (PO) Vaccine Administration MERCK
43
5/9/201543 Oral (PO) Administration Follow instructions per package insert Assess ability to swallow Assess for allergies/contraindications and precautions Assess fluid needs and restriction Remain with client until all medication is swallowed If patient spits up, do not re-administer medication
44
5/9/201544 Intranasal Injection Technique CA DPH
45
5/9/201545 Intranasal Administration Administer as directed according to package insert If dose is divided in the sprayer, half the contents of the dose should be sprayed into each nostril at the same visit Tell the patient to breathe normally (do not sniff) Do not repeat if the person sneezes, coughs or some dribbles out after administration
46
5/9/201546 Infection Control Hand Hygiene Required between patients and before vaccine/medication administration Alcohol-based hand sanitizer can be used when soap and water unavailable Gloves not required unless: potential for exposure to blood or body fluids open lesions on hands agency policy If you do wear gloves, change between each patient
47
5/9/201547 Infection Control (cont.) Follow blood-borne pathogen policy (including needle stick policy) Use PPE (personal protective equipment) as required Immediately dispose of used or contaminated syringes, vials, nasal sprayers, and oral vaccine ampules, as medical waste in sharps/biohazard container Never detach, recap or cut a used needle
48
5/9/201548 Patient Preparation Display confidence and establish a sense of security and trust with the patient Prepare patients for administration; consider their age and stage of development Encourage parents/patients to take active role before, during and after administration Use age-appropriate techniques that provide distraction and minimize the stress and discomfort of vaccination
49
5/9/201549 Patient Comfort & Safety Have patients seated for vaccination Strongly recommend patients are observed for 15-20 minutes after they are vaccinated If syncope develops, patients should be observed until symptoms resolve Counsel patient about the use of pain relievers to decrease discomfort and possible fever post vaccination
50
5/9/201550 Expect the Unexpected While anaphylactic/allergic reactions following vaccinations are rare, you need to be ready to respond with personnel, facilities and equipment/supplies. Emergency Standing Orders need to be current and signed by physician or Medical Director prior to clinic Have emergency supplies available and know how to use them Model Emergency Standing Orders can be found at: http://www.mass.gov/dph/imm http://www.mass.gov/dph/imm
51
5/9/201551 Positioning CA DPH
52
5/9/201552 Positioning CA DPH
53
5/9/201553 Suggested Vaccination/Medication Dispensing Station Supplies Vaccine/medication Cold packs w/plastic containers Needles (different sizes) Safety syringes Sharps/biohazard containers Latex free gloves Hand sanitizer Water/cups Pill crusher Medicine cups Teaspoons/bowls Alcohol wipes Gauze/bandages Adhesive tape Tissues/paper towels Table covering Trash container/bag Required forms/pens
54
5/9/201554 Required Documentation for Administration of Vaccine Patient’s name and age Vaccine name, manufacturer, lot number, expiration date and dose number Publication date on VIS, date VIS was given Anatomical site, route and dose amount Date vaccine administered Vaccinator’s name, initials, address, signatures, and credentials Clinic name, address and contact person Signed consent is not required except when a parent/guardian is not present
55
5/9/201555 Emergency Supplies BP and stethoscope (child & adult, extra- large cuffs) Cell phone or access to an on-site phone 3x3 gauze pads Alcohol wipes Bandages Hand sanitizer Latex free vinyl gloves (small, medium, large & extra large) Flashlight & batteries Thermometer & probe covers Instant cold packs Cots, Blankets, Pillows Wrist watch with second hand
56
5/9/201556 Emergency Supplies (cont.) Acetaminophen 325 mg tablets Ibuprofen 200mg tablets Diphenhydramine 25 mg tablets Diphenhydramine 50 mg injectable-(carpujet) Epipen & Epipen Jr. & Aqueous Epinephrine 1:1000 injectable 1mg/ml Diphenhydramine elixir 12.5 mg/5ml suspension 25 mg/5ml Syringes-3mL-1” 23g, 5/8” 25g, 1mL Ammonia inhalant Airways (large & small) Pocket masks with one way valve (adult & pediatric) Tongue depressors AED
57
5/9/201557 Vaccine/Medication Errors Report error immediately to direct supervisor Monitor client for adverse reaction (if appropriate) Frequently seen errors: Wrong vaccine, medication Wrong dose for age Wrong site, route or needle length Expired/recalled vaccine, medication or diluent Wrong time, errors in spacing of doses Report vaccine/medication administration errors to the Institute for Safe Medication Practices www.ismp.orgwww.ismp.org
58
ISMP Institute of Safe Medication Practices Report medication/vaccine administration errors to ISMP online at: www.ismp.org Institute for Safe Medication Practices 200 Lakeside Drive; Suite 200 Horsham, PA 19044-2321 Phone: 215-947-7797 Fax: 215-914-1492
59
VAERS Vaccine Adverse Event Reporting System Report all clinically significant post- vaccination events via online, mail, phone or fax www.vaers.hhs.gov VAERS P.O. Box 1100, Rockville, MD 20849-1100 1-800-338-2382 (phone) 1-877-721-0366 (fax)
60
5/9/201560 Vaccinator/Dispenser Responsibilities Be informed about storage, handling, preparation, administration and contraindications of vaccine/medication to be administered/dispensed Relay information on the risks and benefits of accepting or refusing vaccine/medication Screen for contraindications and precautions prior to administration Be mindful of security and safety of vaccine/medication, sharps and biohazards
61
5/9/201561 Vaccinator/Dispenser Responsibilities (cont.) Understand documentation used for administration/dispensing Complete required documentation accurately and legibly Be able to access and use emergency equipment Hold current licensure and/or certification (e.g. CPR) Report adverse events (ISMP & VAERS) Report vaccine/medication errors
62
5/9/201562 Medication Storage and Handling Follow package insert and manufacturer’s instruction Be mindful of security and safety of medication at your station
63
5/9/201563 Vaccine Storage and Handling The cold chain begins with the manufacturer and ends with administration of the vaccine to the patient Proper storage temperatures must be maintained per manufacturer recommendations Injectable vaccine syringes/vials maximum 30 minutes at room temperature IN sprayers kept at 2 - 8° C (35 - 46°F) Protect vaccine from exposure to light Keep vaccine on cold packs at stations CDC
64
5/9/201564 MDPH Contact Numbers MDPH Epidemiology/Immunization Program 617-983-6800 (24x7) 888-658-2850 MDPH Vaccine Unit 617-983-6828
65
5/9/201565 Please join us for the other training modules! Planning a Clinic/EDS/POD: November 12 th, 3:00-4:30 All-Staff Briefing & Just-In-Time Training: November 15 th, 3:00-4:30 Vaccine Management, Storage and Handling: November 16 th, 3:00-4:00
66
5/9/201566 Vaccine Key Resources MDPH Guidelines for Compliance with Federal and State Vaccine Administration Requirements http:/www.mass.gov/Eeohhs2/docs/dph/cdc/immunization/guidelines_v accine_compliance.pdf http:/www.mass.gov/Eeohhs2/docs/dph/cdc/immunization/guidelines_v accine_compliance.pdf MDPH General Protocols for Vaccine Storage, Administration, Standing Orders, and Mass Immunization Clinics, Sept 2009 http://www.mass.gov/Eeohhs2/docs/dph/cdc/immunization/mso_protoc ols_general.pdf http://www.mass.gov/Eeohhs2/docs/dph/cdc/immunization/mso_protoc ols_general.pdf MMWR: General Recommendations on Immunization, Recommendations of the Advisory Committee on Immunization Practices (ACIP), December 2006 http://www.cdc.gov/mmwr/pdf/rr/rr5515.pdf http://www.cdc.gov/mmwr/pdf/rr/rr5515.pdf Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) from the CDC http://www.cdc.gov/vaccines/pubs/pinkbook/default.htm#download
67
5/9/201567 Online Resources Massachusetts Department of Public Health, Immunization Program www.mass.gov/dph/imm www.mass.gov/dph/imm CDC: Vaccines and Immunizations http://www.cdc.gov/vaccines http://www.cdc.gov/vaccines World Health Organization: Department of Immunization, Vaccines and Biologicals http://www.who.int/immunization/en http://www.who.int/immunization/en National Vaccine Program Office (NVPO) @ HHS http://www.hhs.gov/nvpo http://www.hhs.gov/nvpo Red Book: 2009 Report of the Committee on Infectious Diseases of the American Academy of Pediatrics http://aapredbook.aappublications.org/ http://aapredbook.aappublications.org/
68
5/9/201568 Online Resources Massachusetts Department of Public Health, School Health Division http://mass.gov/dph/fch/schoolhealth California Department of Public Health, Immunization Branch http://www.eziz.org http://www.eziz.org Immunization Action Coalition http://www.immunize.org
69
5/9/201569 Online Resources MDPH: Recommendations for Drawing-Up Vaccine and Other Documentations Requirements for Clinical Sessions or Large Clinics (Nov 2009) http://www.mass.gov/Eeohhs2/docs/dph/cdc/immunization/mso_r ecommendation_drawing_up_vaccine.pdf http://www.mass.gov/Eeohhs2/docs/dph/cdc/immunization/mso_r ecommendation_drawing_up_vaccine.pdf CDC’s Guide to Vaccine Contraindications and Precautions http://www.cdc.gov/vaccines/recs/vac- admin/downloads/contraindications-guide-508.pdf http://www.cdc.gov/vaccines/recs/vac- admin/downloads/contraindications-guide-508.pdf Institute for Safe Medication Practices http://www.ismp.org http://www.ismp.org Vaccine Adverse Events Reporting System (VAERS) http://www.vaers.hhs.gov http://www.vaers.hhs.gov
70
5/9/201570 QUESTIONS?? Thank You !
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.